Market Cap

Chengdu Easton Biopharmaceuticals Co. Ltd Market Capitalization:

CN¥10.72 Billion

CNY as of Jan. 1, 2026

US$1.53 Billion

business Chengdu Easton Biopharmaceuticals Co. Ltd Company Profile

Chengdu Easton Biopharmaceuticals Co. Ltd Main Stock Listing

SSE: 688513

Market Capitalization History of Chengdu Easton Biopharmaceuticals Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Chengdu Easton Biopharmaceuticals Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2026 CN¥10.72 B 81.68%
Jan. 1, 2025 CN¥5.90 B -15.80%
Jan. 1, 2024 CN¥7.00 B -5.31%
Jan. 1, 2023 CN¥7.40 B 30.18%
Jan. 1, 2022 CN¥5.68 B 3.09%
Jan. 1, 2021 CN¥5.51 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Chengdu Easton Biopharmaceuticals Co. Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Chengdu Easton Biopharmaceuticals Co. Ltd has the following listings and related stock indices.


Stock: SSE: 688513

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.